Search Results - "Henry, Jake Y."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Enhanced cross‐priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide by Henry, Jake Y., Labarthe, Marie‐Christine, Meyer, Brendan, Dasgupta, Prokar, Dalgleish, Angus G., Galustian, Christine

    Published in Immunology (01-07-2013)
    “…Summary The IMiDs® immunomodulatory compounds lenalidomide and pomalidomide are agents with anti‐inflammatory, immunomodulatory and anti‐cancer activity. An…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells by Menger, Laurie, Gouble, Agnes, Marzolini, Maria A.V., Pachnio, Annette, Bergerhoff, Katharina, Henry, Jake Y., Smith, Julianne, Pule, Martin, Moss, Paul, Riddell, Stanley R., Quezada, Sergio A., Peggs, Karl S.

    Published in Blood (24-12-2015)
    “…Cytomegalovirus (CMV) infection is responsible for substantial morbidity and mortality after allogeneic hematopoietic stem cell transplant. T-cell immunity is…”
    Get full text
    Journal Article
  13. 13

    CMV promotes recipient T-cell immunity following reduced-intensity T-cell–depleted HSCT, significantly modulating chimerism status by Sellar, Rob S., Vargas, Frederick Arce, Henry, Jake Y., Verfuerth, Stephanie, Charrot, Sarah, Beaton, Brendan, Chakraverty, Ronjon, Quezada, Sergio A., Mackinnon, Stephen, Thomson, Kirsty J., Peggs, Karl S.

    Published in Blood (22-01-2015)
    “…Cytomegalovirus (CMV) remains a significant cause of morbidity after allogeneic hematopoietic stem cell transplantation (HSCT). Clinical risk varies according…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro by Liu, Wai M, Laux, Holger, Henry, Jake Y, Bolton, Thomas B, Dalgleish, Angus G, Galustian, Christine

    Published in Molecular biology reports (01-04-2010)
    “…Thalidomide and lenalidomide are FDA approved for the treatment of multiple myeloma, and along with pomalidomide are being investigated in a variety of other…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20